Heuron is a venture company founded in 2017 by Dr. Dong-Hoon Shin, CEO, medical doctor, and professor at Gachon University Gil Hospital with faculty members of the departments of neurology, radiology, and medical engineering, as well as doctoral researchers of artificial intelligence from the Gachon University Medical Device Center. In 2017, Dr. Shin’s research was selected as a national project by the Ministry of Health and Welfare for the development of biomarkers for Parkinson's disease (research funding of 1 billion KRW), laying the foundation for the company's establishment. As a medical AI company led by a clinician, Heuron raised much attention from investors because of its specialty and high level of technology in central nervous system diseases. In May 2021, Heuron successfully received 15 billion KRW in Series C funding with an accumulated funding amount of 33 billion KRW (27 million USD).